{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:21:43Z","timestamp":1790644903801,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Antibodies directed against HLA can develop through pregnancy, blood transfusions, or organ transplants. Anecdotal evidence suggests that virus-specific antibodies may have the capacity to cross-react with HLA, a phenomenon called heterologous immunity, which is well described for T-cell alloreactivity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To determine whether antibody cross-reactivity between viral antigens and HLA is common, we tested 51 virus-specific human monoclonal antibodies (mAbs) specific for human immunodeficiency virus, varicella zoster virus, cytomegalovirus, and parvovirus, for reactivity against HLA class I and class II in single-antigen bead assays. In addition, we tested the reactivity of 41 HLA-specific human mAbs against common viral antigens of cytomegalovirus, varicella zoster virus, human immunodeficiency virus, Epstein-Barr virus, and BK polyomavirus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>No cross-reactivity of any of the virus-specific mAbs with either HLA class I or class II molecules, as well as no cross-reactivity of any of the HLA-specific mAbs with any of the viral antigens was observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings indicate that the frequency of cross-reactivity on the antibody level between viral antigens and HLA, if present at all, is low. The emergence of HLA antibodies upon viral infection or vaccination is therefore probably due to bystander activation of dormant HLA-specific memory B cells.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002369","type":"journal-article","created":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T22:59:14Z","timestamp":1531781954000},"page":"1844-1849","source":"Crossref","is-referenced-by-count":11,"title":["No Evidence for Cross-reactivity of Virus-specific Antibodies With HLA Alloantigens"],"prefix":"10.1097","volume":"102","author":[{"given":"Sebastiaan","family":"Heidt","sequence":"first","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariet C.","family":"Feltkamp","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca E","family":"Karahan","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"de Brouwer","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Leiden University Medical Center, Leiden, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Langerak-Langerak","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arend","family":"Mulder","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans H.J.","family":"Claas","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/j.1600-6143.2009.02742.x","article-title":"Contribution of naive and memory T-cell populations to the human alloimmune response","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00251-011-0590-0","article-title":"TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition","volume":"64","year":"2012","journal-title":"Immunogenetics"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOT.0000000000000218","article-title":"T-cell alloreactivity and transplantation outcome: a budding role for heterologous immunity?","volume":"20","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.179.4.1155","article-title":"An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease","volume":"179","year":"1994","journal-title":"J Exp Med"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1399-0039.2009.01311.x","article-title":"New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire","volume":"74","year":"2009","journal-title":"Tissue Antigens"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common","volume":"115","year":"2010","journal-title":"Blood"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/ajt.14279","article-title":"Allo-HLA cross-reactivities of cytomegalovirus-, influenza-, and varicella zoster virus-specific memory T cells are shared by different healthy individuals","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/TP.0b013e318208c071","article-title":"Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2017.03.004","article-title":"Stimulation of HIV-specific T cell clonotypes using allogeneic HLA","volume":"316","year":"2017","journal-title":"Cell Immunol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.4049\/jimmunol.1201034","article-title":"Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules","volume":"189","year":"2012","journal-title":"J Immunol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1600-6143.2009.02764.x","article-title":"Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/tid.12006","article-title":"Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients","volume":"14","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00251-017-0989-3","article-title":"Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms","volume":"69","year":"2017","journal-title":"Immunogenetics"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1600-6143.2009.02789.x","article-title":"Proinflammatory events and HLA antibodies: nothing to sneeze at","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1600-6143.2010.03013.x","article-title":"Proinflammatory events and HLA antibodies","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2012.02.003","article-title":"Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals","volume":"427","year":"2012","journal-title":"Virology"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"e10254","DOI":"10.1371\/journal.pone.0010254","article-title":"Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes","volume":"5","year":"2010","journal-title":"PLoS One"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/JVI.02202-05","article-title":"Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of human immunodeficiency virus type 1","volume":"80","year":"2006","journal-title":"J Virol"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"9035","DOI":"10.1128\/JVI.76.18.9035-9045.2002","article-title":"Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades","volume":"76","year":"2002","journal-title":"J Virol"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4049\/jimmunol.150.2.635","article-title":"Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120","volume":"150","year":"1993","journal-title":"J Immunol"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1073\/pnas.88.8.3238","article-title":"Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein","volume":"88","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.86.5.1624","article-title":"Generation of human monoclonal antibodies to human immunodeficiency virus","volume":"86","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/jvi.65.9.4832-4838.1991","article-title":"Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies","volume":"65","year":"1991","journal-title":"J Virol"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1128\/jvi.65.8.4169-4176.1991","article-title":"Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro","volume":"65","year":"1991","journal-title":"J Virol"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/jvi.63.6.2674-2679.1989","article-title":"Oligomeric structure of gp41, the transmembrane protein of human immunodeficiency virus type 1","volume":"63","year":"1989","journal-title":"J Virol"},{"key":"bib27-20231002","first-page":"609","article-title":"Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function","volume":"3","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","year":"1990","journal-title":"J Immunol"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","year":"2011","journal-title":"J Virol"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/JVI.07163-11","article-title":"Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design","volume":"86","year":"2012","journal-title":"J Virol"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","year":"2012","journal-title":"J Virol"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","year":"2013","journal-title":"Immunity"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.02561-12","article-title":"Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH\/gL complex and neutralizes VZV infection","volume":"87","year":"2013","journal-title":"J Virol"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1472-6750-8-85","article-title":"Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells","volume":"8","year":"2008","journal-title":"BMC Biotechnol"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1399-0039.1993.tb02162.x","article-title":"A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA-A2 subtypes and HLA-A28","volume":"42","year":"1993","journal-title":"Tissue Antigens"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.molimm.2009.10.004","article-title":"Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation","volume":"47","year":"2010","journal-title":"Mol Immunol"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jcv.2015.07.051","article-title":"BK-polyomavirus seroreactivity measured in kidney donors is strongly associated with incidence of viremia and nephropathy in their recipients","volume":"70","year":"2015","journal-title":"J Clin Virol"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0b013e3182007b74","article-title":"Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets","volume":"90","year":"2010","journal-title":"Transplantation"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.humimm.2011.11.011","article-title":"Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies","volume":"73","year":"2012","journal-title":"Hum Immunol"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/JVI.02378-14","article-title":"Polyreactivity and autoreactivity among HIV-1 antibodies","volume":"89","year":"2015","journal-title":"J Virol"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1084\/jem.20121977","article-title":"Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies","volume":"210","year":"2013","journal-title":"J Exp Med"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humimm.2008.10.013","article-title":"Peripheral blood B cells producing donor-specific HLA antibodies in vitro","volume":"70","year":"2009","journal-title":"Hum Immunol"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1600-6143.2011.03982.x","article-title":"A novel ELISPOT assay to quantify HLA-specific B Cells in HLA-immunized individuals","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.humimm.2015.01.014","article-title":"Quantification of HLA class II-specific memory B cells in HLA-sensitized individuals","volume":"76","year":"2015","journal-title":"Hum Immunol"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/ajt.14293","article-title":"A memory B cell crossmatch assay for quantification of donor-specific memory B cells in the peripheral blood of HLA-immunized individuals","volume":"17","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:01:13Z","timestamp":1696222873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201811000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002369","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}